DE69322106T2 - Imidizolderivate mit Anti-HIV-Aktivität - Google Patents
Imidizolderivate mit Anti-HIV-AktivitätInfo
- Publication number
- DE69322106T2 DE69322106T2 DE69322106T DE69322106T DE69322106T2 DE 69322106 T2 DE69322106 T2 DE 69322106T2 DE 69322106 T DE69322106 T DE 69322106T DE 69322106 T DE69322106 T DE 69322106T DE 69322106 T2 DE69322106 T2 DE 69322106T2
- Authority
- DE
- Germany
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- aryl
- hiv activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C07D233/62—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with triarylmethyl radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP557792 | 1992-01-16 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69322106D1 DE69322106D1 (de) | 1998-12-24 |
| DE69322106T2 true DE69322106T2 (de) | 1999-04-29 |
Family
ID=11615084
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69322106T Expired - Fee Related DE69322106T2 (de) | 1992-01-16 | 1993-01-15 | Imidizolderivate mit Anti-HIV-Aktivität |
| DE69330072T Expired - Fee Related DE69330072T2 (de) | 1992-01-16 | 1993-01-15 | Imidazolderivate mit Anti-HIV-Aktivität |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69330072T Expired - Fee Related DE69330072T2 (de) | 1992-01-16 | 1993-01-15 | Imidazolderivate mit Anti-HIV-Aktivität |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US5326780A (de) |
| EP (2) | EP0552060B1 (de) |
| JP (1) | JP3464498B2 (de) |
| KR (1) | KR100259309B1 (de) |
| AT (2) | ATE173470T1 (de) |
| AU (1) | AU649906B2 (de) |
| CA (1) | CA2087112A1 (de) |
| DE (2) | DE69322106T2 (de) |
| DK (2) | DK0700911T3 (de) |
| ES (2) | ES2125301T3 (de) |
| GR (1) | GR3035646T3 (de) |
| HU (1) | HU219917B (de) |
| NZ (1) | NZ245674A (de) |
| PT (1) | PT700911E (de) |
| TW (1) | TW235963B (de) |
| ZA (1) | ZA93217B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5300519A (en) * | 1988-07-06 | 1994-04-05 | The University Of Sheffield | Immunosuppressive agents |
| US5514781A (en) * | 1994-04-11 | 1996-05-07 | Bayer Corporation | Use of azoles as virucidal agents in solutions of biologically active proteins |
| US5922751A (en) * | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
| WO1996010019A1 (fr) * | 1994-09-26 | 1996-04-04 | Shionogi & Co., Ltd. | Derive imidazole |
| ATE286884T1 (de) * | 1996-03-28 | 2005-01-15 | Shionogi & Co | Durch lymphe absorbierbare imidazolderivate |
| WO1997036881A1 (en) * | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5891889A (en) * | 1996-04-03 | 1999-04-06 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| KR100310888B1 (ko) * | 1996-04-04 | 2001-12-12 | 시오노 요시히코 | 이미다졸유도체를함유하는항-hiv조성물 |
| US6544193B2 (en) * | 1996-09-04 | 2003-04-08 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
| US6057448A (en) * | 1996-12-26 | 2000-05-02 | Shionogi & Co., Ltd. | Process for producing imidazole derivatives |
| TWI232214B (en) * | 1998-04-16 | 2005-05-11 | Shionogi & Co | Preparation of aryl sulfenyl halide |
| US6184241B1 (en) | 1998-08-24 | 2001-02-06 | Kansas State University Research Foundation | Aspartic protease inhibitors |
| AU758325C (en) | 1998-12-24 | 2004-10-07 | Astellas Pharma Inc. | Imidazole compounds and medicinal use thereof |
| GB0028484D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Imidazolone derivatives for the treatment of viral diseases |
| IL157453A0 (en) * | 2001-02-23 | 2004-03-28 | K U Leuven Res & Dev K U Leuve | Hiv inhibiting n-aminoimidazole derivatives |
| AU2013403917A1 (en) | 2013-11-04 | 2016-04-28 | Covidien Lp | Surgical fastener applying apparatus |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63150266A (ja) * | 1986-12-12 | 1988-06-22 | Mitsui Petrochem Ind Ltd | ベンジルイミダゾ−ル誘導体 |
| US5668136A (en) * | 1990-09-25 | 1997-09-16 | Eisai Co., Ltd. | Trisubstituted benzene derivatives, composition and methods of treatment |
-
1993
- 1993-01-11 TW TW082100124A patent/TW235963B/zh active
- 1993-01-12 US US08/003,126 patent/US5326780A/en not_active Expired - Lifetime
- 1993-01-12 CA CA002087112A patent/CA2087112A1/en not_active Abandoned
- 1993-01-13 JP JP00421693A patent/JP3464498B2/ja not_active Expired - Fee Related
- 1993-01-13 ZA ZA93217A patent/ZA93217B/xx unknown
- 1993-01-13 NZ NZ245674A patent/NZ245674A/en unknown
- 1993-01-15 AT AT93300278T patent/ATE173470T1/de not_active IP Right Cessation
- 1993-01-15 ES ES93300278T patent/ES2125301T3/es not_active Expired - Lifetime
- 1993-01-15 EP EP93300278A patent/EP0552060B1/de not_active Expired - Lifetime
- 1993-01-15 DE DE69322106T patent/DE69322106T2/de not_active Expired - Fee Related
- 1993-01-15 AU AU31827/93A patent/AU649906B2/en not_active Ceased
- 1993-01-15 KR KR1019930000496A patent/KR100259309B1/ko not_active IP Right Cessation
- 1993-01-15 DE DE69330072T patent/DE69330072T2/de not_active Expired - Fee Related
- 1993-01-15 DK DK95203023T patent/DK0700911T3/da active
- 1993-01-15 EP EP95203023A patent/EP0700911B1/de not_active Expired - Lifetime
- 1993-01-15 PT PT95203023T patent/PT700911E/pt unknown
- 1993-01-15 ES ES95203023T patent/ES2157291T3/es not_active Expired - Lifetime
- 1993-01-15 DK DK93300278T patent/DK0552060T3/da active
- 1993-01-15 AT AT95203023T patent/ATE200082T1/de not_active IP Right Cessation
- 1993-01-15 HU HU9300107A patent/HU219917B/hu not_active IP Right Cessation
-
1994
- 1994-03-14 US US08/209,627 patent/US5472965A/en not_active Expired - Fee Related
-
2001
- 2001-03-29 GR GR20010400136T patent/GR3035646T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK0552060T3 (da) | 1999-08-02 |
| EP0552060B1 (de) | 1998-11-18 |
| ES2157291T3 (es) | 2001-08-16 |
| EP0552060A1 (de) | 1993-07-21 |
| KR930016402A (ko) | 1993-08-26 |
| KR100259309B1 (ko) | 2000-08-01 |
| AU649906B2 (en) | 1994-06-02 |
| US5472965A (en) | 1995-12-05 |
| HU9300107D0 (en) | 1993-04-28 |
| DE69330072T2 (de) | 2001-08-23 |
| AU3182793A (en) | 1993-07-22 |
| ATE173470T1 (de) | 1998-12-15 |
| DE69322106D1 (de) | 1998-12-24 |
| ZA93217B (en) | 1993-08-18 |
| JP3464498B2 (ja) | 2003-11-10 |
| EP0700911A1 (de) | 1996-03-13 |
| ES2125301T3 (es) | 1999-03-01 |
| PT700911E (pt) | 2001-07-31 |
| TW235963B (de) | 1994-12-11 |
| CA2087112A1 (en) | 1993-07-17 |
| ATE200082T1 (de) | 2001-04-15 |
| DK0700911T3 (da) | 2001-05-07 |
| JPH05255270A (ja) | 1993-10-05 |
| US5326780A (en) | 1994-07-05 |
| DE69330072D1 (de) | 2001-05-03 |
| HU219917B (hu) | 2001-09-28 |
| HUT63615A (en) | 1993-09-28 |
| GR3035646T3 (en) | 2001-06-29 |
| EP0700911B1 (de) | 2001-03-28 |
| NZ245674A (en) | 1995-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69322106D1 (de) | Imidizolderivate mit Anti-HIV-Aktivität | |
| PL292101A1 (en) | Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine | |
| FI103508B1 (fi) | Menetelmä anti-inflammatorisen aktiivisuuden omaavien 2-substituoitujen tiatsolidinonien, oksatsolidinonien ja imidatsolidinonien 3,5-di-tert.butyyli-4-hydroksifenyylimetyleenijohdannaisten valmistamiseksi | |
| FI892497A (fi) | Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi | |
| FR2526659B1 (fr) | Medicaments immunomodulants a base de derives de l'acide phenylacetique | |
| DE69428142D1 (de) | Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung | |
| ES2106058T3 (es) | Derivados de benzamida. | |
| YU47973B (sh) | S-enantiomerni glutaramidi i postupak za njihovo dobijanje | |
| DK15387A (da) | 3-aminopropyloxyphenylderivater | |
| AU3624089A (en) | Analgesic phenothiazine derivatives | |
| FI904728A0 (fi) | Benzanilider. | |
| ES2068407T3 (es) | Tratamiento de apneas durante el sueño con derivados de azapirona. | |
| DK0541322T3 (da) | 1-Alkyl-2-acyl-1,2-disulfonylhydraziner med antineoplastisk aktivitet | |
| HU912216D0 (en) | Process for the production of purinyl-and pirimidinyl - tetrahydrofurane derivatives and medical preparations containing them | |
| PT90815A (pt) | Processo de preparacao de derivados da fenotiazina | |
| JPS56131551A (en) | Tyrosine derivative and medicinal use | |
| ATE111919T1 (de) | Antibiotikum-derivat. | |
| KR940002252A (ko) | 우수한 항균작용을 갖는 신규한 피리돈 카르복실산 유도체 및 그의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |